20th World Conference on Pharmaceutical Chemistry and Drug Design

Nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women’s health Nanomedicine is the application of  nanotechnology  in the field of medicine with a view to enhancing the diagnosis and treatment of various diseases. Nanotechnology is already involved in a range of biomedical applications including drug and vaccine delivery, diagnostic imaging, nanosensor diagnostics, nano-enabled therapies, and tissue engineering. A growing recognition of the specific health care requirements of women has resulted in the proposed organizational changes in the provision of health care, focusing predominantly on a life course approach to women’s health care. As our understanding of the benefits of nanomaterial-based agents and diagnostics continues to grow in terms of selectivity, sensitivity, affinity, and detection limits, there is a widespread anticipation that nanotechnology will play an increasing rol

Who suffers from the continued reliance on animal models? Alike animals, humans are derived complex systems. Just because we humans are made up of complementary divisions it doesn't mean those divisions are acting in harmony in a specie and behave correspondingly in another when dug up to a treatment but frequently they don't. Different species are evolved from different starting conditions, giving rise to differences that are unpredictable, the way we respond to drugs can be different from the way the animals respond to drugs, even when the is of Chimpanzees and Humans where they share a great deal of DNA. Patients suffer when drugs that appeared safe in animals end up hurting humans or being ineffective for Humans. It can be explained with the help of example, the painkiller Vioxx was linked to tens of thousands of heart attacks in humans after being deemed not only safe in animals but also beneficial to the heart. Scientists have rectified cancer in m

Scientists profess that they are a step ahead to develop male contraceptive pill which will also increase libido https://drug-chemistry.pharmaceuticalconferences.com/abstract-submission.php Drug Designing : In Melbourne researchers and scientists are developing a contraceptive pill for masculine. They are near to developing a male contraceptive version of the pill that includes the perk effect of increasing libido. This is initiated by Dr Sab Ventura who expatiates in Drug Discovery Biology and his team say the drug blocks the transport of sperm, which is different to existing versions of the male pill which have hormonal targets or reduce the fertilization capability of sperm. If the next stage of drug development comes out to be successful, then the pill will be in the market in coming 5-10 years following the clinical trial phases. The scientists assert that the pill is a hormone-free formula that is set to bypass the side-effects like libido, birth defects a

As the   pharmaceutical   industry faces increasing pressure to accelerate drug development, many contract development organizations are recommending early development programs.   Scientists discussed the current roadblocks in the traditional   drug development   process and explains how productivity can be improved and timelines shortened by implementing a new approach the company refers to as Translational Pharmaceutics.   Be the part of   20th World Conference on Pharmaceutical Chemistry and Drug Design   in Dubai, UAE during September 03-05, 2018. Describe the state of affairs of researches, thesis, projects and enlighten us with your innovation and meet pharmacists, apothecaries, druggists, scientists, experts and technologists. https://drug-chemistry.pharmaceuticalconferences.com There are many factors that can delay the development and eventual commercialization of   novel therapeutics . One of the most intractable factors is the conventional trial-and-error approach

The challenge of maximizing drug safety and maintaining public confidence has become increasingly complex. Pharmaceutical and biotechnology companies must not only monitor, but also proactively assess and manage drug risk throughout a product’s lifecycle, from development to post market.   20th World Conference on Pharmaceutical Chemistry and Drug Design  is going to be held in Dubai during September 03-05 2018, under the enclosed title  "Pharmacovigilance" https://drug-chemistry.pharmaceuticalconferences.com/ Pharmacovigilance : WHO defined as 'the pharmacological science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem’ An umbrella term used to describe the processes for monitoring and evaluating ADRs is a key component of effective drug regulation systems, clinical practice and public health programs. It is the study of the safety of marketed drugs examined unde